癌症幸存者使用避孕药具的情况、临床实践和患者的偏好。

IF 1.8 Q3 OBSTETRICS & GYNECOLOGY
Open access journal of contraception Pub Date : 2024-12-11 eCollection Date: 2024-01-01 DOI:10.2147/OAJC.S431366
Giorgia Asinaro, Sara Stigliani, Edoardo Chiappe, Matteo Lambertini, Claudia Massarotti
{"title":"癌症幸存者使用避孕药具的情况、临床实践和患者的偏好。","authors":"Giorgia Asinaro, Sara Stigliani, Edoardo Chiappe, Matteo Lambertini, Claudia Massarotti","doi":"10.2147/OAJC.S431366","DOIUrl":null,"url":null,"abstract":"<p><p>Current literature suggests that emergency contraception, defined as a therapy aimed at preventing an unwanted pregnancy after unprotected or insufficiently protected intercourse, is used more by cancer survivors than by the general population. This may be related to reduced use of contraception in women after cancer diagnosis and, when it is used, to a choice of less effective methods, even in the absence of contraindications to hormonal options. The purpose of this review is to analyze the use of contraception in these patients, its predictors and the preferred methods, as well as to try to define timing and characteristics of an effective contraception counseling. Factors identified as predictors of contraception usage were younger age, having a partner and better sexual function, having children, past use and having received contraception counseling by a gynecologist, especially in the previous year. Contraception counseling should start before oncological therapies, together with information regarding fertility and sexual health, preferably by the gynecologist of the oncofertility unit, with a specific expertise in dealing with cancer patients. Increased awareness of oncologists and family medicine doctors is fundamental to optimize contraception use and compliance with the prescribed method. Major guidelines regarding oncological care in women of fertile age already recommend contraception counseling, but optimal timing and mode of the consultation(s) options should be further researched, to be better detailed in all relevant documents.</p>","PeriodicalId":74348,"journal":{"name":"Open access journal of contraception","volume":"15 ","pages":"135-143"},"PeriodicalIF":1.8000,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646390/pdf/","citationCount":"0","resultStr":"{\"title\":\"Contraception Use in Cancer Survivors, Clinical Practice and Patients' Preferences.\",\"authors\":\"Giorgia Asinaro, Sara Stigliani, Edoardo Chiappe, Matteo Lambertini, Claudia Massarotti\",\"doi\":\"10.2147/OAJC.S431366\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Current literature suggests that emergency contraception, defined as a therapy aimed at preventing an unwanted pregnancy after unprotected or insufficiently protected intercourse, is used more by cancer survivors than by the general population. This may be related to reduced use of contraception in women after cancer diagnosis and, when it is used, to a choice of less effective methods, even in the absence of contraindications to hormonal options. The purpose of this review is to analyze the use of contraception in these patients, its predictors and the preferred methods, as well as to try to define timing and characteristics of an effective contraception counseling. Factors identified as predictors of contraception usage were younger age, having a partner and better sexual function, having children, past use and having received contraception counseling by a gynecologist, especially in the previous year. Contraception counseling should start before oncological therapies, together with information regarding fertility and sexual health, preferably by the gynecologist of the oncofertility unit, with a specific expertise in dealing with cancer patients. Increased awareness of oncologists and family medicine doctors is fundamental to optimize contraception use and compliance with the prescribed method. Major guidelines regarding oncological care in women of fertile age already recommend contraception counseling, but optimal timing and mode of the consultation(s) options should be further researched, to be better detailed in all relevant documents.</p>\",\"PeriodicalId\":74348,\"journal\":{\"name\":\"Open access journal of contraception\",\"volume\":\"15 \",\"pages\":\"135-143\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-12-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646390/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open access journal of contraception\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/OAJC.S431366\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open access journal of contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OAJC.S431366","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目前的文献表明,癌症幸存者比普通人群更常使用紧急避孕药,紧急避孕药的定义是一种旨在防止无保护或保护不足的性交后意外怀孕的疗法。这可能与女性在确诊癌症后减少使用避孕药物有关,也可能与使用紧急避孕药物时选择了效果较差的方法有关,即使在没有激素禁忌症的情况下也是如此。本综述旨在分析这些患者使用避孕药具的情况、其预测因素和首选方法,并尝试确定有效避孕咨询的时间和特点。经确认,预测使用避孕药具的因素包括年龄较小、有性伴侣且性功能较好、有子女、过去使用过避孕药具以及接受过妇科医生的避孕咨询,尤其是在过去一年中。避孕咨询应在肿瘤治疗前开始,同时提供有关生育和性健康的信息,最好由具有治疗癌症患者专业知识的肿瘤科妇科医生提供。提高肿瘤科医生和家庭医生的认识,对于优化避孕药具的使用和遵守处方方法至关重要。有关育龄妇女肿瘤治疗的主要指南已经建议进行避孕咨询,但应进一步研究咨询的最佳时间和方式,并在所有相关文件中进行更详细的说明。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Contraception Use in Cancer Survivors, Clinical Practice and Patients' Preferences.

Current literature suggests that emergency contraception, defined as a therapy aimed at preventing an unwanted pregnancy after unprotected or insufficiently protected intercourse, is used more by cancer survivors than by the general population. This may be related to reduced use of contraception in women after cancer diagnosis and, when it is used, to a choice of less effective methods, even in the absence of contraindications to hormonal options. The purpose of this review is to analyze the use of contraception in these patients, its predictors and the preferred methods, as well as to try to define timing and characteristics of an effective contraception counseling. Factors identified as predictors of contraception usage were younger age, having a partner and better sexual function, having children, past use and having received contraception counseling by a gynecologist, especially in the previous year. Contraception counseling should start before oncological therapies, together with information regarding fertility and sexual health, preferably by the gynecologist of the oncofertility unit, with a specific expertise in dealing with cancer patients. Increased awareness of oncologists and family medicine doctors is fundamental to optimize contraception use and compliance with the prescribed method. Major guidelines regarding oncological care in women of fertile age already recommend contraception counseling, but optimal timing and mode of the consultation(s) options should be further researched, to be better detailed in all relevant documents.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信